Breastfeeding warning
Use during breastfeeding only on medical advice.
Leaflet MELLEVA 35 2mg / 0.035mg film-coated tablets
- Product code:
- W52427001
- Quantity:
- 1
- Indicated for:
- androgen-dependent acne; hirsutism; contraception
- Route of administration:
- oral
- Substance:
- cyproterone + ethinylestradiol (antiandrogen + estrogen)
- ATC
- G03HB01 — Genito urinary system and sex hormones | Antiandrogens | Antiandrogens and estrogens
Precautions:
The combination of cyproterone and ethinylestradiol is used for the treatment of severe acne, hirsutism, and other conditions caused by excess androgens in women. Cyproterone is an antiandrogen that reduces the effects of androgen hormones, while ethinylestradiol is an estrogen that regulates the menstrual cycle.
The medication is taken orally, as directed by a doctor, usually once daily at the same time each day. It is important for patients to follow the treatment regimen to achieve maximum benefits.
Patients should be aware of potential side effects, such as nausea, headaches, or mood changes. It is important to inform the doctor of any unusual symptoms.
Common side effects include nausea, headaches, and breast tenderness. In rare cases, severe reactions such as venous thromboembolism or allergic reactions may occur. Patients should be informed of these risks before starting treatment.
The medication is taken orally, as directed by a doctor, usually once daily at the same time each day. It is important for patients to follow the treatment regimen to achieve maximum benefits.
Patients should be aware of potential side effects, such as nausea, headaches, or mood changes. It is important to inform the doctor of any unusual symptoms.
Common side effects include nausea, headaches, and breast tenderness. In rare cases, severe reactions such as venous thromboembolism or allergic reactions may occur. Patients should be informed of these risks before starting treatment.
General data about MELLEVA 35 2mg / 0.035mg
- Substance:
- cyproterone + ethinylestradiol
- Date of latest medicines list:
- 01-01-2014
- Product code:
- W52427001
- Concentration:
- 2mg / 0.035mg
- Pharmaceutical form:
- film-coated tablets
- Quantity:
- 1
- Product type:
- Generic medicine
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.